What is the current Biopharmaceuticals Contract Manufacturing Market size?

In 2024, the Biopharmaceuticals Contract Manufacturing Market size is expected to reach USD 41.71 billion. Read More

Who are the key players in Biopharmaceuticals Contract Manufacturing Market?

Boehringer Ingelheim GmbH, JRS Pharma (Celonic), Lonza Group, Rentschler Biotechnologie GmbH and Inno Biologics Sdn Bhd are the major companies operating in the Biopharmaceuticals Contract Manufacturing Market. Read More

Which is the fastest growing region in Biopharmaceuticals Contract Manufacturing Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Biopharmaceuticals Contract Manufacturing Market?

In 2024, the North America accounts for the largest market share in Biopharmaceuticals Contract Manufacturing Market. Read More

What years does this Biopharmaceuticals Contract Manufacturing Market cover, and what was the market size in 2023?

In 2023, the Biopharmaceuticals Contract Manufacturing Market size was estimated at USD 36.69 billion. The report covers the Biopharmaceuticals Contract Manufacturing Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Biopharmaceuticals Contract Manufacturing Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Biopharmaceuticals Contract ManufacturingCompanies

Q: How big is the Biopharmaceuticals Contract Manufacturing Market?

The Biopharmaceuticals Contract Manufacturing Market size is expected to reach USD 41.71 billion in 2024 and grow at a CAGR of 13.68% to reach USD 79.19 billion by 2029. Read More

This report lists the top Biopharmaceuticals Contract Manufacturing companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Biopharmaceuticals Contract Manufacturing industry.